Actuate Therapeutics Share Price Today
(NASDAQ: ACTU)

Name: Actuate Therapeutics Share Price Today (NASDAQ: ACTU) - Actuate Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Actuate Therapeutics share price is $7.13 & ₹620.09 as on 6 Mar 2025, 2.30 'hrs' IST

$7.13

▲

0.11

(1.57%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Actuate Therapeutics share price in Dollar and Rupees. Guide to invest in Actuate Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Actuate Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Actuate Therapeutics share price movements

Today's Low: $6.88
Today's High: $7.37
$7.13
3.58%
Downside
Day's Volatility :6.72%
Upside
3.26%
52 Weeks Low: $5.51
52 Weeks High: $11.73
$7.13
22.72%
Downside
52 Weeks Volatility :53.03%
Upside
39.22%

Actuate Therapeutics (ACTU) Returns

Period	Actuate Therapeutics	Index (Russel 2000)
3 Months	-19.86%	0.0%
6 Months	-13.87%	0.0%
1 Year	-18.47%	0.0%
3 Years	-18.47%	-11.6%

Actuate Therapeutics (ACTU) Key Statistics

in dollars & INR

Previous Close	$7.02
Open	$7.28
Today's High	$7.37
Today's Low	$6.875
Market Capitalization	$152.9M
Today's Volume	$4.3K
52 Week High	$11.73
52 Week Low	$5.51
Revenue TTM	$0.0
Earnings Per Share (EPS)	$-1.85
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Actuate Therapeutics Stock (ACTU) from India?

It is very easy for Indian residents to invest directly in Actuate Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Actuate Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Actuate Therapeutics or ACTU on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Actuate Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Actuate Therapeutics shares which would translate to 0.122 fractional shares of Actuate Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Actuate Therapeutics, in just a few clicks!

Returns in Actuate Therapeutics (ACTU) for Indian investors in Rupees

The Actuate Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Actuate Therapeutics investment value today

Current value as on today

₹87,773

Returns

₹12,227

(-12.23%)

Returns from Actuate Therapeutics Stock

₹17,189 (-17.19%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Actuate Therapeutics (ACTU)

-86%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Actuate Therapeutics Stock from India on INDmoney has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Actuate Therapeutics

Insights on Actuate Therapeutics Stock (Ticker Symbol: ACTU)

Price Movement
In the last 1 month, ACTU stock has moved down by -25.6%

Actuate Therapeutics Technicals Summary

Sell

Neutral

Buy

Actuate Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Actuate Therapeutics (ACTU) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Actuate Therapeutics	-24.19%	-13.87%	-18.47%	-18.47%	-18.47%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Actuate Therapeutics	NA	NA	NA	0.0	0.0	0.0	NA	-63.74
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Actuate Therapeutics	NA	$152.9M	-18.47%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Actuate Therapeutics

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.

Organization	Actuate Therapeutics
Employees	11
CEO	Mr. Daniel M. Schmitt
Industry	Miscellaneous

Management People of Actuate Therapeutics

Name	Title
Mr. Daniel M. Schmitt	CEO, President & Director
Dr. Andrew P. Mazar Ph.D.	Co-Founder & COO
Dr. Alan Kozikowski Ph.D.	Scientific Founder and Advisor
Mr. Paul J. Lytle CPA	Chief Financial Officer

Important FAQs about investing in ACTU Stock from India :

What is Actuate Therapeutics share price today?

Actuate Therapeutics share price today stands at $7.13, Open: $7.28 ; Previous Close: $7.02 ; High: $7.37 ; Low: $6.88 ; 52 Week High: $11.73 ; 52 Week Low: $5.51.

The stock opens at $7.28, after a previous close of $7.02. The stock reached a daily high of $7.37 and a low of $6.88, with a 52-week high of $11.73 and a 52-week low of $5.51.

Can Indians buy Actuate Therapeutics shares?

Yes, Indians can invest in the Actuate Therapeutics (ACTU) from India.

With INDmoney, you can buy Actuate Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Actuate Therapeutics at zero transaction cost.

How can I buy Actuate Therapeutics shares from India?

It is very easy to buy Actuate Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Actuate Therapeutics (ACTU) be purchased?

Yes, you can buy fractional shares of Actuate Therapeutics with INDmoney app.

What are the documents required to start investing in Actuate Therapeutics stocks?

To start investing in Actuate Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.